<DOC>
	<DOCNO>NCT02969083</DOCNO>
	<brief_summary>The aim study explore feasibility Upper Tract Urothelial Carcinoma ( UTUC ) treatment base real world data various European country . The study allow gain insight true proportion patient fit receive complete cisplatin-based neo-adjuvant adjuvant chemotherapy , proportion clinical outcome patient poor prognostic factor ( PS renal function ) receive standard treatment ( Radical nephroureterectomy ( RNU ) ) . This comparison make use uniform diagnostic treatment protocol .</brief_summary>
	<brief_title>Feasibility Neo-adjuvant Versus Adjuvant Chemotherapy Upper Tract Urothelial Carcinoma</brief_title>
	<detailed_description>There definitive treatment recommendation patient diagnose UTUC . Radical nephroureterectomy ( RNU ) consider gold standard treatment UTUC . However due high recurrence rate report , patient often offer perioperative chemotherapy provide good renal function performance status . With regard choice chemotherapy treatment , also clear recommendation since data randomize study . If perioperative chemotherapy consider daily practice , gemcitabine/cisplatin regimen often choose occasionally dd-MVAC . The aim study explore feasibility UTUC treatment base real world data various European country . Patients fulfil good prognostic factor ( inclusion criterion treatment randomization ) allocate neo-adjuvant ( Arm B ) adjuvant ( Arm C ) chemotherapy ( receive 3 cycle gemcitabine/cisplatin dose dense Methotrexate , Vinblastine , Adriamycin , Cisplatin ( MVAC ) . Patients n't fulfil criterion treatment randomization undergo Radical nephroureterectomy ( RNU ) ( Arm A ) . Patients follow 5 year .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Dactinomycin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Written inform consent Age &gt; 18 year Histological radiological define UTUC : Histologicallyconfirmed diagnosis predominantly urothelial carcinoma upper urinary tract Patients UTUC cT2pT4 cN0N1 M0 ( TNM classification ) Women negative serum pregnancy test within 14 day first dose study treatment agreement use effective contraception Patients without bladder cancer concomitant non muscle invasive bladder cancer Adequate organ system function define follow : Hematologic : Absolute neutrophil count ( ANC ) 1.5 X 109/L ; Haemoglobin 5.6 mmol/L ( 9.02g/dL ) ; Platelets 100 X 109/L ; Prothrombin time ( PT ) international normalize ratio ( INR ) b 1.2 X ULN ; Activated partial thromboplastin time ( aPTT ) 1.2 X Upper limit normal ( ULN ) . Hepatic : Total bilirubin 1.5 X ULN ; Alanine amino transferase ( ALT ) Aspartate aminotransferase ( AST ) 2.5 X ULN . Renal : GRF &lt; &gt; 55 ml/min : Electrolytes : potassium , magnesium calcium : within normal limit . CT scan chest , abdomen pelvis Bone scan without evidence distant metastasis Histology pure adenocarcinoma , pure squamous cell carcinoma , sarcomatoid predominant small cell carcinoma . History cardiovascular condition within past 6 month . Incidentally find asymptomatic pulmonary embolism ( PE ) recent deep vein thrombosis ( DVT ) exclusion criterion require anticoagulation treatment . Any major contraindication surgical procedure . Any serious and/or unstable preexist medical , psychiatric , condition could interfere subject 's safety , provision inform consent , compliance study procedure . Active infection contraindicate chemotherapy Concomitant diseases formal exclusion platinumbased chemotherapy ( deafness , grade II neuropathy ) . Other active neoplasm . Patients situ cervical carcinoma , nonmelanoma skin cancer prostate cancer T1 Gleason &lt; 7 , Prostate specific antigen ( PSA ) &lt; 10 . Patients past medical history cancer include diagnose least 5 year ago . Concomitant muscle invasive bladder cancer Patients still methotrexate treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>UTUC</keyword>
	<keyword>Upper Tract Urothelial Carcinoma</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
	<keyword>Radical nephroureterectomy</keyword>
</DOC>